INT — Intellego Technologies AB Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Intellego Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | PRESS | PRESS |
| Standards: | SAS | — | SAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.03 | -16.8 | 68.8 | -15.2 | -175 |
| Depreciation | |||||
| Non-Cash Items | — | 15.2 | 9.85 | -3.61 | 107 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.44 | 4.72 | -98.8 | 12.7 | 123 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.46 | 3.13 | -20.1 | -6.06 | 55 |
| Capital Expenditures | -0.468 | -1.58 | -28.8 | -28.6 | -1.18 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.02 | 4.7 | -7.48 | -4.12 | -9.84 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.488 | 3.12 | -36.3 | -32.7 | -11 |
| Financing Cash Flow Items | -3.47 | -0.174 | -0.429 | -2.25 | -0.983 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.7 | 29.3 | 19.3 | 41.9 | 234 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.79 | 36 | -36.7 | 3.41 | 277 |